Regenicin Inc (CE) (RGIN) Börsenkurse

Form 8-K/A - Current report: [Amend]

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form 8-K - Current report

Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus

Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus The Company values the sale from the Asset Purchase Agreement at $8.023 million. PR Newswire LITTLE FALLS, N.J., March 3...

Regenicin Enters Into Asset Purchase Agreement with Amarantus Bioscience Holdings, Inc.

Regenicin Enters Into Asset Purchase Agreement with Amarantus Bioscience Holdings, Inc. PR Newswire LITTLE FALLS, N.J., Nov. 19, 2014 LITTLE FALLS, N.J., Nov. 19, 2014 /PRNewswire/ -- Regenicin...

Clarification of Prior Press Release on FDA Issuance of Orphan Status for PermaDerm® -Regenicin, Inc.

Clarification of Prior Press Release on FDA Issuance of Orphan Status for PermaDerm® -Regenicin, Inc. PR Newswire LITTLE FALLS, N.J., June 13, 2012 LITTLE FALLS, N.J., June 13, 2012...

FDA Issues Orphan Status Approval for PermaDerm®

FDA Issues Orphan Status Approval for PermaDerm® PR Newswire LITTLE FALLS, N.J., June 12, 2012 LITTLE FALLS, N.J., June 12, 2012 /PRNewswire/ -- Regenicin, Inc. (OTC Bulletin Board: RGIN) a...

BUYINS.NET Issues Regenicin SqueezeTrigger Report

Approximately 8 Million Shares Shorted Since November 2010 First Short Squeeze Expected Above $0.30 SqueezeTrigger Price NEWPORT BEACH, Calif., June 28, 2011 (GLOBE NEWSWIRE...

PermaDerm™ Receives National Media Coverage

PermaDerm™ Receives National Media Coverage PR Newswire LITTLE FALLS, N.J., March 8, 2011 LITTLE FALLS, N.J., March 8, 2011 /PRNewswire/ -- PermaDerm™, an engineered skin substitute which is...